Red Clover (Trifolium pratense) Monograph

Bibliography

• Ingram D, Sanders K, Kolybaba M, et al. Case-control study of phyto-oestro-gens and breast cancer. Lancet 1997; 350(9083)990–994
   PubMed Web of Science ®Google Scholar
• Clifton-Bligh P B, Baber R J, Fulcher G R, et al. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001; 8(4)259–265
   PubMed Web of Science ®Google Scholar
• Knight D C. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2: 79–84
   PubMedGoogle Scholar
• Nestel P J, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endo-crinol Metab 1999; 84(3)895–898
   PubMed Web of Science ®Google Scholar
• Atkinson C, Compston J E, Robins S P, et al. The effects of isoflavone phyto-estrogens on bone; preliminary results from a large randomized controlled trial. Endocr Soc Annu Meet Program 2000; 82: 196
   Google Scholar
• Atkinson C, Warren R M, Dowsett M, et al. Effects of isoflavones on breast density, oestradiol, and gonadotrophins: a double blind randomized placebo controlled trial. Poster presented at The Endocrine Society's 83rd Annual Meeting. 2000
   Google Scholar
• Zava D T, Dollbaum C M, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 1998; 217(3)369–378
   PubMed Web of Science ®Google Scholar
• Baber R, Clifton Bligh P, Fulcher G, et al. The effect of an isoflavone extract (PO81) on serum lipids, forearm bone density and endometrial thickness in post-menopausal women [Abstract]. Proceedings of the North American Menopause Society, New York, 1999
   Google Scholar
• Nachtigall L B, La Grega L, Lee W W, . The effects of isoflavones derived from red clover on vasomotor symptoms and endometrial thickness. 9th International Menopause Society World Congress on the Menopause, YokohamaJapan. A Takeshi, Y Takumi, T Yuji, et al. 1999; 331–336
   Google Scholar
• van de Weijer Barentsen R. Isoflavones from red clover (Promensil(r)) significantly reduce hot flashes compared with placebo. Poster presented at The North American Menopause Society's 12th Annual Meeting, New Orleans, 2001
   Google Scholar
• Jeri A R. The effect of isoflavone phytoestrogens in relieving hot flushes in Peruvian postmenopausal women. 9th International Menopause Society World Congress on the Menopause, YokohamaJapan, 1999
   Google Scholar
• Samman S, Lyons Wall PM, Chan G S, et al. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premeno-pausal women. Atherosclerosis 1999; 147(2)277–283
   PubMed Web of Science ®Google Scholar
• Stephens F O. Phytoestrogens and prostate cancer: possible preventive role. Med J Aust 1997; 167(3)138–140
   PubMed Web of Science ®Google Scholar
• Howes J B, Sullivan D, Lai N, et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000; 152(1)143–147
   PubMed Web of Science ®Google Scholar
• Umland E M, Cauffield J S, Kirk J K, et al. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy 2000; 20(8)981–990
   PubMed Web of Science ®Google Scholar
• Messina M, Barnes S, Setchell K D. Phyto-oestrogens and breast cancer. Lancet 1997; 350(9083)971–972
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke L, Cho E, Onojafe I, et al. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 1999; 6(5)1089–1095
   PubMed Web of Science ®Google Scholar
• Zand R S, Jenkins D J, Diamandis E P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000; 62(1)35–49
   PubMed Web of Science ®Google Scholar
• Liu J, Burdette J E, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001; 49(5)2472–2479
   PubMed Web of Science ®Google Scholar
• Knight D C, Eden J A. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87(5 Pt 2)897–904
   PubMed Web of Science ®Google Scholar
• Yanagihara K, Ito A, Toge T, et al. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993; 53(23)5815–5821
   PubMed Web of Science ®Google Scholar
• Barnes S, Kim H, Darley-Usmar V, et al. Beyond ERalpha and ERbeta: estrogen receptor binding is only part of the isoflavone story. J Nutr 2000; 130((3))656S–657S
   PubMed Web of Science ®Google Scholar
• Domon O E, McGarrity L J, Bishop M, et al. Evaluation of the genotoxicity of the phytoestrogen, coumestrol, in AHH-1 TK(+/2) human lymphoblastoid cells. Mutat Res 2001; 474(1–2)129–137
   PubMed Web of Science ®Google Scholar
• Setchell K D, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129((3))758S–767S
   PubMed Web of Science ®Google Scholar
• Setchell K D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68((6 Suppl))1333S–1346S
   PubMed Web of Science ®Google Scholar
• Abernathy K, Brockie J, Suffling K, et al. An open study of the effects of a 40 mg isoflavone food supplement (derived from red clover), on menopausal symptoms. The British Menopause Society. 2001
   Google Scholar
• Simons L A, von Konigsmark M, Simons J, et al. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000; 85(11)1297–1301
   PubMed Web of Science ®Google Scholar
• Finking G, Wohlfrom M, Lenz C, et al. The phytoestrogens Genistein and Daidzein, and 17 beta-estradiol inhibit development of neointima in aortas from male and female rabbits in vitro after injury. Coron Artery Dis 1999; 10(8)607–615
   PubMed Web of Science ®Google Scholar
• Hodgson J M, Puddey I B, Beilin L J, et al. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 1998; 128(4)728–732
   PubMed Web of Science ®Google Scholar
• Anderson J W, Johnstone B M, Cook-Newell M E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333(5)276–282
   PubMed Web of Science ®Google Scholar
• Lovati M R, Manzoni C, Canavesi A, et al. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987; 80(5)1498–1502
   PubMed Web of Science ®Google Scholar
• Gerber G, Lowe F C, Spigekman S. The use of a standardized extract of red clover isoflavones for the alleviation of BPH symptoms. The Endocrine Society's 82nd Annual Meeting. 2000; 2359, 82
   Google Scholar
• Le Bail J C, Champavier Y, Chulia A J, et al. Effects of phytoestrogens on aromatase, 3 beta and 17 beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 2000; 66(14)1281–1291
   PubMed Web of Science ®Google Scholar
• Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophos-phorylation. Prostate 1993; 22(4)335–345
   PubMed Web of Science ®Google Scholar
• Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991; 179(1)661–667
   PubMed Web of Science ®Google Scholar
• Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125((3 Suppl))777S–783S
   PubMed Web of Science ®Google Scholar
• Jadad A R, Moore R A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17((1))1–12
   PubMedGoogle Scholar